Immutep Limited EBIT

Immutep Limited (IMMP) currently reports a EBIT of $-140M as of December 2025. That compares with $-87M in the prior-year period — down 56.2% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore Immutep Limited's EBIT history and peer comparisons.

Immutep Limited's EBIT decreased from $-87M to $-140M — a 56.2% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Immutep Limited's EBIT of $-140M is lower than the Healthcare sector average of $22B. That is roughly 100.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Immutep Limited reported $-140M in EBIT as of December 2025. That compares with $-87M in the prior-year period — down 56.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-140M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for Immutep Limited, and consider following IMMP for alerts when major investors trade the stock.